Jane Street’s Immunocore IMCR Stock Holding History

Jane Street’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Sell	70,100 -262,600	-79%	-$7.77M	﹤0.01%	4989
2026 Q1	$10M	Buy	+332,700	New	+$10.8M	﹤0.01%	2532
2025 Q4	–	Sell	-13,700	Closed	-$498K	–	11724
2025 Q3	$498K	Sell	13,700 -49,000	-78%	-$1.66M	﹤0.01%	7876
2025 Q2	$1.97M	Buy	+62,700	New	+$1.95M	﹤0.01%	4441
2024 Q4	–	Sell	-152,200	Closed	-$4.74M	–	9958
2024 Q3	$4.74M	Buy	+152,200	New	+$5.54M	﹤0.01%	2950
2024 Q2	–	Sell	-28,700	Closed	-$1.87M	–	9755
2024 Q1	$1.87M	Buy	+28,700	New	+$1.97M	﹤0.01%	4255
2023 Q1	–	Sell	-29,700	Closed	-$1.69M	–	9434
2022 Q4	$1.69M	Sell	29,700 -30,900	-51%	-$1.74M	﹤0.01%	4105
2022 Q3	$2.85M	Buy	60,600 +2,700	+5%	+$129K	﹤0.01%	3551
2022 Q2	$2.16M	Buy	+57,900	New	+$1.88M	﹤0.01%	4022

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street's IMCR Position: Q2 2026 in Review

Jane Street increased its Immunocore (IMCR) stake by 14% in Q2 2026, buying an estimated $857K and bringing the position to 233,348 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Jane Street first reported a position in IMCR in Q2 2022 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Jane Street held 233,348 shares of Immunocore worth $7.41M as of Q2 2026.
Jane Street bought 28,980 Immunocore shares in Q2 2026, an estimated $857K.
Immunocore made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3194 holding.
Jane Street first reported a position in Immunocore in Q2 2022 and has held it in 15 quarters since.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.